AI’s role in medicine isn’t monolithic, says industry leader, urging nuanced adoption

Priya Abani, CEO of health‑tech firm AliveCor, argues that asking whether AI is good for medicine is a question with an obvious answer: it is. She says the debate has become redundant and that the focus should shift to how AI is applied.

She cites a recent Nature Medicine study titled “Is AI actually improving healthcare?” which confirms AI’s benefits but also notes that many tools are too new to prove patient‑outcome improvements.

Abani warns against treating AI as a single, mysterious force, likening the misconception to assuming lasers always improve surgery. With three‑quarters of U.S. health systems using at least one AI application, nuanced evaluation is essential.

She criticizes sensational headlines that fuel skepticism and calls for careful, evidence‑based assessment of each AI tool rather than blanket judgments.